ANXA1 overexpression
|
AML
|
ANXA1 overexpression
|
AML
|
MDX-124 Sensitive: D – Preclinical
|
MDX-124 Sensitive: D – Preclinical
|
ANXA1 overexpression
|
Triple Negative Breast Cancer
|
ANXA1 overexpression
|
Triple Negative Breast Cancer
|
MDX-124 Sensitive: D – Preclinical
|
MDX-124 Sensitive: D – Preclinical
|